Myelodysplastic syndrome differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 22: | Line 22: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 17:19, 26 August 2015
Myelodysplastic syndrome Microchapters |
Differentiating Myelodysplastic syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Myelodysplastic syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Myelodysplastic syndrome differential diagnosis |
Risk calculators and risk factors for Myelodysplastic syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The differential diagnosis is that of anemia, thrombocytopenia, and/or leukopenia. Usually, the elimination of known etiologies of cytopenias, along with a dysplastic bone marrow, is required to diagnose a myelodysplastic syndrome.
Differenting Myeloproliferative disease from other Diseases
Differential Diagnosis (for dysplasia)
- Arsenic, Lead, Benzene, Xylene, petroleum, Agent Orange (Vietnam Veterans).
- Congenital Dyserythropoietic anemia
- HIV
- Vitamin B12 / folate
- Parvovirus
- Alcohol abuse
- Prior chemotherapy (eg. melphalan, mustard, chlorambucil, busulfan, cyclophosphamide).
- Radiation (with or without chemotherapy).